SARS-CoV
SARS-CoV (severe acute respiratory syndrome-cornavirus) is an enveloped positive-sense single-stranded RNA viruse that transmitted from human to human.
Products for SARS-CoV
- Cat.No. Product Name Information
-
GC40559
(±)-Alliin
(±)-Allyl-L-cysteine sulfoxide
Alliin is a cysteine sulfoxide constituent of garlic that is converted by alliinase to allicin, which imparts its pungent aroma and flavor. -
GC40560
(+)-Alliin
S-Allyl-L-cysteine sulfoxide
Alliin is a cysteine sulfoxide constituent of garlic that is converted by alliinase to allicin, which imparts its pungent aroma and flavor. -
GC39317
(S)-Tenofovir
(S)-Tenofovir ((S)-GS 1278) is the less active S-enantiomer of Tenofovir.
-
GC71928
1,7-Bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one
1,7-Bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one is a potent nucleocapsid (N) protein inhibitor can be isolated from Curcuma kwangsiensis.
-
GC71925
10-Hydroxyaloin A
10-10-Hydroxyaloin A is potent SARS-CoV-2 inhibitor.
-
GC61674
2-Hydroxyacetophenone
2-Hydroxyacetophenone is a principal root volatile of the Carissa edulis.
-
GC61753
2-Hydroxycinnamic acid
2-Hydroxycinnamic acid is isolated from the methanol extract of Cinnamomum cassia.
-
GC35144
4'-O-Methylbavachalcone
4'-O-Methylbavachalcone is a chalcone isolated from Psoralea corylifolia, inhibits severe acute respiratory syndrome coronavirus (SARS-CoV) papain-like protease (PLpro) activity, with an IC50 of 10.1 μM.
-
GC62354
Acriflavine hydrochloride
Acriflavine hydrochloride (Acriflavinium chloride hydrochloride) is a fluorescent acridine dye that can be used to label nucleic acid.
-
GC72385
Adintrevimab
Adintrevimab (ADG 20) is a human IgG1 monoclonal SARS-CoV (SARS-CoV) antibody.
-
GC72389
Amubarvimab
Amubarvimab (BRII-196) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a KD of 5.88 nM.
-
GC60051
Anti-MERS-2E6 mAb
MERS-2E6; MERS Antibody-2E6
Anti-MERS-2E6 mAb (MERS-2E6; MERS Antibody-2E6), a human neutralizing antibody IgG1 (CHO expressed) that can compete for the binding of the virus Spike protein to the receptor (CD26), thereby inhibiting virus invasion into host cells. -
GC60052
Anti-MERS-3A1 mAb
MERS-3A1; MERS Antibody-3A1
Anti-MERS-3A1 mAb (MERS-3A1) is a human monoclonal IgG1 antibody with the high binding affinity produced in CHO cells. -
GC66241
Anti-MERS-D12 mAb
MERS-D12; MERS Antibody-D12
Anti-MERS-D12 mAb (MERS-D12; MERS Antibody-D12) is a human monoclonal IgG1. Anti-MERS-D12 mAb binds directly to the DPP4 interacting region of the MERS-CoV Spike receptor binding domain (RBD) and effect neutralization by directly blocking receptor binding. -
GC60054
Anti-SARS-80R mAb
SARS-80R; SARS Antibody-80R
Anti-SARS-80R mAb (SARS-80R) is a human monoclonal IgG1 antibody produced in CHO cells. -
GC60055
Anti-SARS-CoV-2 Spike mAb (CR3022)
SARS-CR3022; SARS-CoV-2 Antibody-CR3022
Anti-SARS-CoV-2 Spike mAb (CR3022) is a a CHO cell derived human monoclonal IgG1 antibody. -
GC60056
Anti-Spike-RBD mAb
SARS-CoV-2 (2019-nCoV) Spike RBD Antibody
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. -
GC60057
Anti-Spike-RBD Single Domain mAb
SARS-CoV-2 (2019-nCoV) Single-Domain Antibodies; Humanized Single Domain Antibody
Anti-Spike-RBD Single Domain mAb is a CHO cell derived Alpaca monoclonal VHH-huFc antibody, specifically binds to SARS-CoV-2 RBD with high affinity. -
GC67913
Antiviral agent 5
-
GC73665
Arbemnifosbuvir
AT-752 free base
Arbemnifosbuvir is a nidovirus DdRp-associated nucleotidyltransferase (NiRAN) domain of non-structural protein 12 (nsp12)-interfering drugs. -
GC62320
AT-511
AT-511
AT-511 (AT-511) is a potent and orally active HCV viral replication inhibitor. -
GC62321
AT-527
Bemnifosbuvir hemisulfate
AT-527(Bemnifosbuvir hemisulfate), a hemisulfate salt of AT-511, a guanosine nucleotide proagent, is a potent and orally active HCV viral replication inhibitor.
-
GC63412
AT-9010 tetrasodium
AT-9010 tetrasodium, a triphosphate active metabolite of AT-527, is a potent inhibitor of NiRAN (a function essential for viral replication).
-
GC17903
Atovaquone
BW 566C, BW 556C-80
unique naphthoquinone with broad-spectrum antiprotozoal activity -
GC65180
ATV006
ATV006
ATV006 is a potent, orally active antiviral agent and ester prodrugs of GS-441524. -
GC14472
Aviptadil
Vasoactive Intestinal Peptide (human, rat, mouse, rabbit, canine, porcine)
Aviptadil is a 28-amino acid neurotransmitter and a vasoactive intestinal polypeptide (VIP) analog. It has an effective vasodilator effect, can induce pulmonary vasodilation, and inhibit vascular smooth muscle cell proliferation and platelet aggregation. -
GC60609
Aviptadil acetate
Aviptadil acetate is an analog vasoactive intestinal polypeptide (VIP) with potent vasodilatory effects.
-
GC46903
Azithromycin-d3
An internal standard for the quantification of azithromycin
-
GC68722
Bamlanivimab
Anti-Human SARS-CoV-2
Bamlanivimab (Anti-Human SARS-CoV-2) was the first COVID-19 monoclonal antibody (mAb) to receive emergency use authorization (EUA) from the US Food and Drug Administration (FDA) in November 2020. However, due to increasing resistance of the SARS-CoV-2 virus variants to Bamlanivimab, it was revoked in April 2021.
-
GC72334
Bebtelovimab
Bebtelovimab a humanized IgG1-λ2 antibody targeting to SARS-CoV-2, especially COVID-19.
-
GC14250
Bepotastine Besilate
Bepotastine besilate, TAU-284
Non-sedating, selective antagonist of histamine 1 (H1) receptor -
GC10959
Boceprevir
Victrelis
An NS3/4A protease inhibitor -
GC46936
Boceprevir-d9
An internal standard for the quantification of boceprevir
-
GC61885
Bonducellpin D
Bonducellpin D is a furanoditerpenoid lactone isolated from Caesalpinia minax.
-
GC72395
Burfiralimab
Burfiralimab (hzVSF-v13) is a monoclonal IgG4 antibody against vimentin expressed on the surface of virus-infected cells, with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation.
-
GC15089
Carfilzomib (PR-171)
PR-171
A proteasome inhibitor -
GC68834
Casirivimab
REGN10933
Casirivimab (REGN10933) is a human monoclonal antibody that targets the SARS-CoV-2 virus that causes COVID-19. Casirivimab lacks efficacy against COVID-19 variants. Casirivimab can be used in combination with Imdevimab to effectively reduce viral load and improve symptoms.
-
GC63779
CCF0058981
CCF981
CCF0058981 (CCF981), 3-chlorophenyl analogue, is a noncovalent SARS-CoV-2 3CLpro (SC2) inhibitor with an IC50 of 68 nM. -
GC31707
Chebulagic acid
Chebulagic acid is a COX-LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz, on angiogenesis.
-
GC19549
Chloroquine
CHLORO QUINE PHOSPHATE; 4-(7-chloro-4-quinolylamino)pentyldiethylamine; (4S)-N~4~-(7-chloroquinolin-4-yl)-N~1~,N~1~-diethylpentane-1,4-diamine
An autophagy and toll-like receptors (TLRs) inhibitor
-
GC60700
Chloroquine D5
Chloroquine D5 is deuterium labeled Chloroquine.
-
GC10295
Chloroquine diphosphate
DL-Chloroquine, NSC 14050
Chloroquine diphosphate is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. -
GC45885
Chloroquine-d5 (phosphate)
DL-Chloroquine-d5
An internal standard for the quantification of chloroquine -
GC64289
Cichoriin
Cichoriin is an active compounds against SARS-CoV-2, and may be a potential candidate in treating severe COVID-19.
-
GC72412
Cilgavimab
Cilgavimab (AZD-1061; COV2-2130) is a human SARS-CoV-2-neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab .
-
GC64264
Cleistanthin B
Cleistanthin B (Diphyllin O-glucoside) is an orally active arylnaphthalene lignan lactone glycoside.
-
GC12635
Clevudine
Levovir, L-FMAU
antiviral drug -
GC12879
Danoprevir (RG7227)
ITMN-191, R-7227
An HCV NS3/4A protease inhibitor -
GC17942
Darunavir Ethanolate
TMC114
nonpeptidic HIV protease inhibitor -
GC12828
Daunorubicin
DNA topoisomerase II inhibitor
-
GC68939
Daxdilimab
MEDI7734; VIB7734
Daxdilimab is an anti-ILT7 monoclonal antibody, where ILT7 is a cell surface molecule specific to pDC-type dendritic cells. Daxdilimab can be used in the research of acute lung injury (ALI) caused by COVID-19 infection.
-
GC61677
Direct Violet 1
Direct Violet 1, an azo dye, is a textile dye.
-
GC18620
EIDD-1931
β-D-N4-Hydroxycytidine, N4-Hydroxycytidine
A ribonucleoside analog with antiviral activity
-
GC18413
EIDD-2801
EIDD2801,EIDD 2801
An orally bioavailable prodrug of the ribonucleoside analog EIDD-1931
-
GC64368
Ensitrelvir fumarate
S-217622
Ensitrelvir (S-217622) fumarate is the first orally active non-covalent, non-peptidic, SARS-CoV-2 3CL protease inhibitor (IC50=13 nM). -
GC70489
Fluphenazine-d8
Fluphenazine-d8 is the deuterium labeled Fluphenazine.
-
GC60856
FOY 251
FOY 251, an anti-proteolytic active metabolite Camostate, acts as a proteinase inhibitor.
-
GC71871
Gallinamide A TFA
Gallinamide A TFA is a linearly depositing peptide and a potent inhibitor of cathepsin L (CatL) (IC50: 17.6 pM).
-
GC62221
GRL-0496
GRL-0496 is a potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitor, with an IC50 of 30 nM in both enzyme inhibitory and antiviral assays.
-
GC71247
GRL-1720 TFA
GRL-1720 TFA is a potent inhibitor of SARS-CoV-2 Mpro with an EC50 value of 15 μM.
-
GC39172
GRL0617
A SARS-CoV and SARS-CoV-2 PLpro inhibitor
-
GC63563
GS-621763
GS-441524 tris-isobutyryl ester
GS-621763, an orally bioavailable prodrug of GS-441524, shows antiviral activity against SARS-CoV-2 pathogenesis in mice. -
GC62414
HCoV-229E-IN-1
HCoV-229E-IN-1 is a potent inhibitor of HCoV-229E replication, with an EC50 of 0.65 μM and 0.6 μM in MTS and CPE cells, respectively.
-
GC63500
HeE1-2Tyr
HeE1-2Tyr, a pyridobenzothiazole compound, is a flavivirus RNA dependent RNA polymerases (RdRp) inhibitor.
-
GC12544
Hydroxychloroquine Sulfate
HCQ, NSC 4375
Autophagy inhibitor
-
GC47445
Hydroxychloroquine-d4 (sulfate)
HCQ-d4
An internal standard for the quantification of hydroxychloroquine -
GC71397
Ibuzatrelvir
Ibuzatrelvir (PF-07817883) is an antiviral agent, targeting to SARS-CoV-2 3CL protease.
-
GC60930
Imatinib D4
Imatinib D4 (STI571 D4) is a deuterium labeled Imatinib (STI571). Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity.
-
GC39612
Imatinib D8
Imatinib D8 (STI571 D8) is a deuterium labeled Imatinib (STI571). Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity.
-
GC69267
Imdevimab
REGN10987
Imdevimab (REGN10987) is a human monoclonal antibody that targets the SARS-CoV-2 virus causing COVID-19. Imdevimab lacks efficacy against COVID-19 variants. Imdevimab can be used in combination with Casirivimab to effectively reduce viral load and improve symptoms.
-
GC43925
Ivermectin B1b
22,23-dihydro Avermectin B1b
Ivermectin B1b is the minor component. -
GC73745
Jun12682
Jun12682 is an inhibitor of SARS-CoV-2 papain-like protease.
-
GC66366
Kansuinine B
Kansuinine B inhibits IL-6-induced Stat3 activation. Kansuinine B possesses anti-viral activity and could be used in the study for COVID-19.
-
GC64263
Kobophenol A
Kobophenol A, an oligomeric stilbene, blocks the interaction between the ACE2 receptor and S1-RBD with an IC50 of 1.81 μM and inhibits SARS-CoV-2 viral infection in cells with an EC50 of 71.6 μM.
-
GC62667
KW-8232
KW-8232, an orally active anti-osteoporotic agent, and can reduces the biosynthesis of PGE2.
-
GC10317
Lamivudine
(-)-BCH 189, 3TC, 2’,3’-dideoxy-3’-Thiacytidine
Nucleoside analog reverse transcriptase inhibitor -
GC17439
Ledipasvir
GS-5885
An HCV NS5A inhibitor -
GC69367
Lenzilumab
KB 003
Lenzilumab (KB 003) is a humanized monoclonal antibody that targets CSF2/GM-CSF and can be used in research for COVID-19, chronic myelomonocytic leukemia (CMML), and juvenile myelomonocytic leukemia (JMML).
-
GC71221
Leritrelvir
Leritrelvir (RAY1216) is an orally active SARS-CoV-2 main protease slow-tight inhibitor with a Ki of 8.6 nM.
-
GC13716
Lopinavir
A157378.0, ABT378
A potent HIV-1 protease inhibitor -
GC47573
Lopinavir-d8
An internal standard for the quantification of lopinavir
-
GC71194
LY1
LY1 is a potent, selective and covalent inhibitor against both SARS-CoV-2 PLpro and Mpro with Kd values of 1.5 μM and 2.3 μM for Mpro C145A protein and PLpro C111A protein, respectively.
-
GC63065
Merafloxacin
CI-934
Merafloxacin (CI-934), a fluoroquinolone antibacterial agent, is a selective programmed -1 ribosomal frameshifting (-1 PRF) inhibitor of beta coronaviruses. -
GC63790
MERS-CoV-IN-1
MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus.
-
GC71631
Methylprednisolone-d7
Methylprednisolone-d7 is deuterium labeled Methylprednisolone.
-
GC14363
Mitoxantrone HCl
NCI 301739, NSC 301739
Mitoxantrone HCl is a potent topoisomerase II inhibitor. -
GC12301
Mizoribine
NSC 289637
DNA/RNA synthesis inhibitor -
GC39497
ML188
ML188, a first in class probe, is a selective non-covalent SARS-CoV 3CLpro inhibitor with an IC50 of 1.5 μM.
-
GC11655
Moexipril HCl
CI-925, RS 10085-197, SPM 925
Moexipril HCl (RS-10085) is an orally active inhibitor of angiotensin-converting enzyme (ACE), and becomes effective by being hydrolyzed to moexiprila (hydrochloride). -
GC62162
Molnupiravir
EIDD-2801, β-D-N4-Hydroxycytidine-5′-isopropyl ester, MK-4482
Molnupiravir (EIDD-2801) is an orally bioavailable prodrug of the ribonucleoside analog EIDD-1931. -
GC67754
Molnupiravir-d7
EIDD-2801-d7; MK-4482-d7
-
GC50727
MPro 13b
MPro 13b is a potent Mpro inhibitor.
-
GC47707
MPro Inhibitor 11a
An inhibitor of SARS-CoV-2 Mpro
-
GC47708
MPro Inhibitor 11b
MPro Inhibitor 11b is a SARS-CoV-2 3CLpro covalent inhibitor, with an IC50 of 40 nM.
-
GC62208
Mpro inhibitor N3 hemihydrate
Mpro inhibitor N3 hemihydrate is a potent inhibitor of SARS-CoV-2 Mpro with an EC50 of 16.77 μM for SARS-CoV-2.
-
GC50732
MPro N3
-
GC69538
Narsoplimab
OMS 721; Anti-MASP2 Reference Antibody (narsoplimab)
Narsoplimab (anti-MASP-2) is a human immunoglobulin gamma 4 (IgG4) monoclonal antibody against mannose-binding protein-associated serine protease 2 (MASP-2) achieved by high affinity (zymogen form: KD=0.062nM, IC50~3.4nM; enzymatically active form: KD=0.089nM) to block lectin pathway. -
GC17709
Nelfinavir
HIV-1 protease inhibitor
-
GC61956
NHC-diphosphate
NHC-diphosphate is an active phosphorylated?intracellular metabolite?of β-d-N4-Hydroxycytidine (NHC) as a diphosphate form.
-
GC61130
NHC-triphosphate
NHC-triphosphate is an active phosphorylated intracellular metabolite of β-d-N4-Hydroxycytidine (NHC) as a triphosphate form.